Gleevec ⁽¹⁾

Gleevec is the trade name for the generic drug name Imatinib Mesylate. ... Drug type: Gleevec is a targeted therapy. Gleevec is classified as a signal transduction inhibitor - protein-tyrosine kinase inhibitor.

Oktay Simsek 29 December 2018

Novartis loses a Glivec patent case in Turkey

The Turkish Constitutional Court has ruled that there has been no violation of the property rights due to the invalidation of one of "Glivec®" patents of Novartis in Turkey. The Swiss pharmaceutical giant Novartis filed an international patent application (International patent application no. PCT/EP2003/004151) designating,…